AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMBBiotechnology
Healthcare
$5.82 +2.48%
+$0.25 today
- Market cap
- $286.62M
- Beta
- 2.62
- P/E (TTM)
- -7.1
- EPS (TTM)
- -$1.28
52W Low $8.75High $17.45
Volume 0.13M
Average 0.14M
Balance Sheet
Inspect the capital base behind the business.
Assets
—
Liabilities
—
Equity
—
Balance Sheet
Currency unavailable
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $129.6M |
| Other Current | $3.4M |
| Total Current Assets | $133.0M |
| PP&E (Net) | $1.7M |
| Goodwill | $8.6M |
| Intangible Assets | $20.1M |
| Long-term Investments | $11.0K |
| Other Non-current | $2.2M |
| Total Non-current Assets | $32.6M |
| Total Assets | $165.6M |
Analysis
Selected assets total $165.6M for Latest. The largest visible component is Cash & Equivalents at $129.6M, about 78.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 6, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 22, 2026 | |
| 6-K | 6-K filing | Oct 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 9, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 7, 2026 |
Continue the stock analysis
Jump to another research area for this company.